We also aim to help better matching of patients to clinical trials and increase accrual of patients on trials, and then learning from the population. And then once you’ve done that, which, to be honest, is a hard and substantial problem in cancer today, then you can think about the right next step.īy way of example: we’ve included game- changers such as Dana-Farber oncology Pathways on oncology pathways. If you want more detail around that, you can start with the localization and characterization directed to integrated diagnostic. Our customers can perform analytics on their populations and learn from the flow of patient cases through the platform.

We’re not a pharmaceutical company, but once you’ve done the right first-time diagnosis, we do think we can inform how you might take the right next step.Īnd then the fourth, which just as important, is doing this in a closed loop framework. Louis: We think about our platform across four pillars: the first three are localization of disease, characterization of disease, and providing therapy guidance and planning. Could you please tell us about Philips Oncology Informatics platform, including its mission and goals.Ī. That’s how we think about precision medicine and precision diagnostics at Philips. We can think about precision medicine to include image-guided interventions such as ablative techniques and so forth. In terms of characterization of disease, we think about doing better by integrating information across modalities such as molecular genomics and imaging features.Īnd then in terms of precision medicine – that’s the other side of this – how are we treating the patient? You could think about it from a purely pharmaceutical perspective, but you could also think of it more broadly in terms of other interventions. We have examples where we combine MR imaging with ultrasound images to provide a better, more accurate, localization picture. Localization is often done with imaging, but also sometimes through integrating imaging sources. Louis: If I start with the concept of a precision diagnosis, we think about getting a first-time right diagnosis for cancer patients, including doing better at localization and characterization of the disease. How does Philips define precision diagnostics and precision medicine?Ī. They have kindly agreed to discuss the program and its aspirations with us. Tolearn more about this platform, we connected with Louis Culot, General Manager, Oncology Informatics and Genomics, and Dr. Philips vision is to become a leader in innovating precision medicine solutions that connect areas such as pathology, genomics, and molecular phenotyping molecular for personalized therapy decision making.

The platform streamlines collaboration, offers a comprehensive molecular picture, and delivers actionable reports for a better path towards precision care. Recognizing the growing need for technological advancement in comprehensive xoncology care, Philips has built its Oncology Informatics and Genomics business on Philips HealthSuite with workflows for pathologists, oncologists, and researchers. Philips approach to precision medicine is to arm care teams to make decisions efficiently, collaboratively, and accurately with expert clinical guidance and a holistic view of a patient’s genotypic and phenotypic information. Precision Medicine is focused on generating and using precision data to develop and deliver drugs for the unmet needs of patient populations who do not respond to the standard of care. An interview with Louis Culot and Qi Wei, Leaders of the Philips Oncology, Informatics Initiatives1,2

Precision diagnostics laboratory